Transgenic Mouse Model of Tauopathies with Glial Pathology and Nervous System Degeneration
Open Access
- 1 August 2002
- Vol. 35 (3) , 433-446
- https://doi.org/10.1016/s0896-6273(02)00789-4
Abstract
No abstract availableKeywords
Funding Information
- National Institute on Aging
This publication has 58 references indexed in Scilit:
- Age-Dependent Induction of Congophilic Neurofibrillary Tau Inclusions in Tau Transgenic MiceThe American Journal of Pathology, 2001
- Transgenic Expression of the Shortest Human Tau Affects Its Compartmentalization and Its Phosphorylation as in the Pretangle Stage of Alzheimer's DiseaseThe American Journal of Pathology, 1999
- Tau Pathology in Two Dutch Families with Mutations in the Microtubule-Binding Region of TauThe American Journal of Pathology, 1998
- Tau is a candidate gene for chromosome 17 frontotemporal dementiaAnnals of Neurology, 1998
- Autosomal dominant dementia with widespread neurofibrillary tanglesAnnals of Neurology, 1997
- Monoclonal antibody PHF‐1 recognizes tau protein phosphorylated at serine residues 396 and 404Journal of Neuroscience Research, 1994
- Abnormal tau phosphorylation at Ser396 in alzheimer's disease recapitulates development and contributes to reduced microtubule bindingNeuron, 1993
- Recognition of the minimal epitope of monoclonal antibody Tau‐1 depends upon the presence of a phosphate group but not its locationJournal of Neuroscience Research, 1993
- Immunological and conformational characterization of a phosphorylated immunodominant epitope on the paired helical filaments found in Alzheimer's diseaseBiochemical and Biophysical Research Communications, 1992
- Appearance of paired nucleated, Tau-positive glia in patients with progressive supranuclear palsy brain tissueNeuroscience Letters, 1992